| Literature DB >> 23300753 |
Thomas Ritz1, Michelle Bosquet Enlow, Stefan M Schulz, Robert Kitts, John Staudenmayer, Rosalind J Wright.
Abstract
Respiratory sinus arrhythmia (RSA) is related to cardiac vagal outflow and the respiratory pattern. Prior infant studies have not systematically examined respiration rate and tidal volume influences on infant RSA or the extent to which infants' breathing is too fast to extract a valid RSA. We therefore monitored cardiac activity, respiration, and physical activity in 23 six-month old infants during a standardized laboratory stressor protocol. On average, 12.6% (range 0-58.2%) of analyzed breaths were too short for RSA extraction. Higher respiration rate was associated with lower RSA amplitude in most infants, and lower tidal volume was associated with lower RSA amplitude in some infants. RSA amplitude corrected for respiration rate and tidal volume influences showed theoretically expected strong reductions during stress, whereas performance of uncorrected RSA was less consistent. We conclude that stress-induced changes of peak-valley RSA and effects of variations in breathing patterns on RSA can be determined for a representative percentage of infant breaths. As expected, breathing substantially affects infant RSA and needs to be considered in studies of infant psychophysiology.Entities:
Mesh:
Year: 2012 PMID: 23300753 PMCID: PMC3530477 DOI: 10.1371/journal.pone.0052729
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Overview of the Still-Face Paradigm.
Percentages of breaths too short to allow extraction of two inter-beat intervals for peak-valley RSA calculation in infants.
| Play | Still-Face1 | Reunion1 | Still-Face2 | Reunion2 | Time (n = 23) | Time (n = 16) | |||
| ( | ( | ( | ( | ( |
|
|
|
| |
| 2.59 | .105 | 1.87 | .111 | ||||||
| Mean | 9.0 | 5.9 | 10.3 | 10.9 | 12.6 | ||||
| Range | 0.8–42.3 | 0–33.3 | 0–28.7 | 0–44.0 | 0–58.2 | ||||
Note: RSA = respiratory sinus arrhythmia; Frequencies across episodes (as % of analyzed breaths) and ANOVA time effects for infants with one Still-Face Test (n = 23, df = 2,44) and two Still-Face Tests (n = 16, df = 4,60).
p<.10.
Means ± standard deviations of respiration-uncorrected and respiration-corrected RSA indices, respiration measures, and HR for Still-Face Test episodes.
| Play | Still-Face1 | Reunion1 | Still-Face2 | Reunion2 | |
| Test 1 ( | |||||
| RSA (ms) | 11.4±4.1 | 9.8±4.8 | 10.8±5.9 | ||
| logRSA (log ms) | 1.47±0.22 | 1.26±0.29 | 1.35±0.29 | ||
| RSAc (ms) | 12.0±1.8 | 10.0±1.7 | 11.3±3.1 | ||
| logRSAc (log ms) | 1.48±0.12 | 1.29±0.17 | 1.38±0.21 | ||
| RSA/VT (ms/mL) | 0.168±0.068 | 0.126±0.066 | 0.129±0.057 | ||
| logRSA/VT (log ms/mL) | 0.136±0.048 | 0.102±0.048 | 0.107±0.042 | ||
| RSA/VTc (ms/mL) | 0.172±0.028 | 0.134±0.033 | 0.136±0.026 | ||
| logRSA/VTc (log s/mL) | 0.139±0.020 | 0.108±0.022 | 0.112±0.020 | ||
| TTOT (s) | 1.31±0.17 | 1.43±0.14 | 1.34±0.16 | ||
| VT (mL) | 86.7±27.4 | 103.1±24.4 | 105.3±36.1 | ||
| HR (b/min) | 135.0±11.5 | 146.6±12.6 | 144.5±11.2 | ||
| Test 1 and 2 ( | |||||
| RSA (ms) | 10.6±3.9 | 9.1±4.5 | 10.0±3.0 | 7.5±4.1 | 9.1±3.8 |
| logRSA (log ms) | 1.43±0.20 | 1.22±0.29 | 1.39±0.29 | 1.08±0.32 | 1.28±0.31 |
| RSAc (ms) | 10.5±1.4 | 8.8±1.5 | 10.1±1.32 | 6.6±2.7 | 8.7±2.5 |
| logRSAc (log ms) | 1.40±0.12 | 1.20±0.17 | 1.37±0.16 | 1.03±0.27 | 1.24±0.23 |
| RSA/VT (ms/mL) | 0.160±0.058 | 0.120±0.061 | 0.130±0.047 | 0.086±0.061 | 0.110±0.052 |
| logRSA/VT (log ms/mL) | 0.132±0.042 | 0.100±0.046 | 0.109±0.035 | 0.072±0.045 | 0.093±0.041 |
| RSA/VTc (ms/mL) | 0.153±0.029 | 0.115±0.030 | 0.124±0.022 | 0.080±0.051 | 0.105±0.044 |
| logRSA/VTc (log ms/mL) | 0.125±0.021 | 0.095±0.022 | 0.105±0.016 | 0.068±0.037 | 0.089±0.032 |
| TTOT (s) | 1.28±0.14 | 1.41±0.11 | 1.30±0.12 | 1.57±0.20 | 1.42±0.15 |
| VT (mL) | 81.4±19.6 | 94.9±22.6 | 94.5±26.7 | 108.9±21.5 | 102.3±26.4 |
| HR (b/min) | 137.4±10.5 | 147.1±12.5 | 142.3±10.2 | 152.1±15.5 | 149.3±16.4 |
Note: HR = heart rate; VT = tidal volume; RSA = respiratory sinus arrhythmia; TTOT = total respiratory cycle time; HR = heart rate; RSA/VT = RSA normalized by VT; c = adjusted for TTOT; logRSA = logarithm(RSA+1); logRSA/VT = logarithm(RSA/VT)+1.
Overall ANOVA time effects (df = 4,66 or 2,44) for changes in physiological parameters across Still-Face Tests and paired t-tests (df = 15 or 22) testing changes from Play to Still-Face episodes 1 and 2.
| Overall ANOVA effect | P vs. SF1 | P vs. SF2 | |||||
|
|
|
|
|
|
|
| |
| Test 1 ( | |||||||
| RSA (mL) | 1.69 | .197 | .071 | 2.75 | .012 | ||
| logRSA/VTc (log ms/mL) | 13.43 | .001 | .379 | 4.99 | .001 | ||
| TTOT (s) | 4.54 | .019 | .171 | 2.56 | .018 | ||
| VT (mL) | 8.53 | .001 | .279 | 4.02 | .001 | ||
| HR (b/min) | 16.16 | .001 | .423 | 7.04 | .001 | ||
| Test 1 and 2 ( | |||||||
| RSA (mL) | 4.36 | .004 | .225 | 3.36 | .008 | 3.75 | .004 |
| logRSA/VTc (log ms/mL) | 8.23 | .001 | .354 | 4.74 | .001 | 4.51 | .001 |
| TTOT (s) | 12.50 | .001 | .454 | 3.13 | .014 | 7.33 | .001 |
| VT (mL) | 7.09 | .001 | .321 | 3.30 | .010 | 5.46 | .001 |
| HR (b/min) | 7.74 | .001 | .340 | 4.95 | .001 | 4.83 | .001 |
Note: P = Play episode; SF1 = Still-Face episode 1; SF2 = Still-Face episode 2; TTOT = total respiratory cycle time; VT = tidal volume; RSA = respiratory sinus arrhythmia; logRSA/VTc = logarithm of RSA normalized by VT (logarithm(RSA/VT)+1), adjusted for TTOT; HR = heart rate.
p-level of both t-tests for each index are Bonferroni-adjusted in this subgroup.
Figure 2RSA (uncorrected and corrected for respiration), respiratory parameters, physical activity and heart rate across the two Still-Face Test challenges (n = 16).
Within-individual association of infant RSA with respiratory parameters TTOT entered in Step 1 and VT entered in Step 2, or in reverse order, calculated across all episodes of the Still-Face Paradigm.
| TTOT (s) | VT (mL) | Multiple | ||||||
|
| range Δ | freq. |
| range Δ | freq. |
| range | |
| Entered as Step 1 | .014 | .000–.095 | 12/23 | .004 | .000–.037 | 8/23 | .179 | .055–.364 |
| Entered as Step 2 | .023 | .001–.109 | 17/23 | .008 | .000–.039 | 12/23 | ||
Note: TTOT = total respiratory cycle time; VT = tidal volume; RSA = respiratory sinus arrhythmia.
frequency of positive within-individual correlations for which p<.10.
range of n = 126–444 breaths.
Figure 3Individual trajectories of RSA uncorrected and corrected for respiration (both tidal volume and respiration rate) across the three episodes of the first Still-Face Test (n = 23).
ANOVA time effects (df = 4,60 or 2,44) and paired t-tests (df = 15 or 22) measuring reduction in additional respiration-uncorrected and corrected RSA indices during Still-Face Test 1 and 2.
| ANOVA time effect | P vs. SF1 | P vs. SF2 | |||||
|
|
|
|
|
|
|
| |
| Test 1 ( | |||||||
| logRSA (log ms) | 6.06 | .009 | .216 | 4.84 | .001 | ||
| RSAc (ms) | 3.52 | .058 | .138 | 4.12 | .001 | ||
| logRSAc (log ms) | 5.95 | .008 | .213 | 4.52 | .001 | ||
| RSA/VT (ms/mL) | 11.75 | .001 | .348 | 4.26 | .001 | ||
| logRSA/VT (log ms/mL) | 14.14 | .001 | .391 | 5.18 | .001 | ||
| RSA/VTc (ms/mL) | 11.44 | .001 | .342 | 4.15 | .001 | ||
| Test 1 and 2 ( | |||||||
| logRSA (log ms) | 6.76 | .003 | .311 | 3.90 | .001 | 4.90 | .001 |
| RSAc (ms) | 7.93 | .002 | .346 | 4.09 | .001 | 4.69 | .001 |
| logRSAc (log ms) | 7.62 | .002 | .337 | 3.77 | .004 | 5.05 | .001 |
| RSA/VT (ms/mL) | 6.74 | .002 | .310 | 4.72 | .001 | 4.06 | .001 |
| logRSA/VT (log ms/mL) | 8.13 | .001 | .352 | 4.98 | .001 | 4.54 | .001 |
| RSA/VTc (ms/mL) | 6.87 | .002 | .315 | 4.53 | .001 | 4.06 | .001 |
Note: VT = tidal volume; RSA = respiratory sinus arrhythmia; TTOT = total respiratory cycle time; HR = heart rate; RSA/VT = RSA normalized by VT; c = adjusted for total respiratory cycle time; logRSA = logarithm(RSA+1); logRSA/VT = logarithm(RSA/VT)+1.
p-level of both tests Bonferroni-adjusted for all indices.
RSA, respiration, and heart rate across Still-Face Test episodes controlled for physical activity: Linear mixed model overall F tests (df = 2 or 4, 50.0 to 67.7), time-varying covariate activity effect F-tests (df = 1, 25.7 to 77.8) and t-tests (df = 52.4 to 77.7) testing changes from Play to Still-Face episode 1 and 2.
| Overall effect | P vs. SF1 | P vs. SF2 | Activity | |||||
|
|
|
|
|
|
|
|
| |
| Test 1 ( | ||||||||
| RSA (ms) | 0.17 | .844 | −0.53 | .599 | 0.73 | .397 | ||
| logRSA/VTc (log ms/mL) | 9.78 | .001 | −3.37 | .001 | 0.42 | .518 | ||
| TTOT (s) | 1.10 | .341 | 1.46 | .149 | 0.91 | .345 | ||
| VT (mL) | 6.36 | .004 | 1.32 | .193 | 1.23 | .273 | ||
| HR (b/min) | 8.67 | .001 | 0.93 | .359 | 14.18 | .001 | ||
| Test 1 and 2 ( | ||||||||
| RSA (ms) | 1.46 | .226 | −0.25 | .803 | −1.59 | .118 | 4.28 | .043 |
| logRSA/VTc (log ms/mL) | 6.93 | .001 | −2.67 | .009 | −5.01 | .001 | 0.23 | .882 |
| TTOT (s) | 5.56 | .001 | 1.60 | .115 | 3.97 | .001 | 1.80 | .184 |
| VT (mL) | 5.06 | .001 | 1.42 | .162 | 3.05 | .003 | 1.21 | .276 |
| HR (b/min) | 3.83 | .007 | 1.03 | .309 | 2.06 | .044 | 7.76 | .007 |
Note: VT = tidal volume; RSA = respiratory sinus arrhythmia; TTOT = total respiratory cycle time; HR = heart rate; RSA/VT = RSA normalized by VT; c = adjusted.
for total respiratory cycle time; logRSA = logarithm(RSA+1); logRSA/VT = logarithm(RSA/VT)+1.